OBJECTIVE-The purpose of this study was to develop a quantitative multiparametric MRI approach to differentiating clear cell renal cell carcinoma (RCC) from other renal cortical tumors.
MATERIALS AND METHODS-This retrospective study included 119 patients with 124histopathologically confirmed renal cortical tumors who underwent preoperative MRI including DWI, contrast-enhanced, and chemical-shift sequences before nephrectomy. Two radiologists independently assessed each tumor volumetrically, and apparent diffusion coefficient values, parameters from multiphasic contrast-enhanced MRI (peak enhancement, upslope, downslope, AUC), and chemical-shift indexes were calculated. Univariate and multivariable logistic regression analyses were performed to identify parameters associated with clear cell RCC.RESULTS-Interreader agreement was excellent (intraclass correlation coefficient, 0.815-0.994). The parameters apparent diffusion coefficient (reader 1 AUC, 0.804; reader 2, 0.807), peak enhancement (reader 1 AUC, 0.629; reader 2, 0.606), and downslope (reader 1 AUC, 0.575; reader Address correspondence to A. M. Hötker (Andreas. Hoetker@uni-mainz.de). This study expands on our earlier investigation (AJR 2016; 206:100-105), in which only DWI results were analyzed. For the current study, similar measurements were added for contrast-enhanced and chemical-shift MRI sequences, which were part of the dedicated renal MRI protocol for all patients.Based on a presentation at the European Congress of Radiology 2015 annual meeting, Vienna, Austria (abstract published in Insights Imaging 2015; 6(suppl 1):S380). . However, given that many renal tumors are incidentally found in frail and elderly patients and that 10-30% of re-sected tumors prove to be benign at histopathologic analysis [3], options such as active surveillance and focal ablation have been introduced to patient care. These alternatives are considered for selected patients for whom less invasive treatment is preferred to radical or partial nephrectomy (the current standard of care). The introduction of these less invasive alternatives has created a great clinical need to correctly characterize renal lesions before treatment selection to avoid undertreatment. Because the role of renal biopsy is still evolving, studies are focusing on approaches to noninvasively identifying aggressive subtypes of RCC by use of imaging.
HHS Public AccessClear cell RCC is known to be a highly vascular tumor compared with, for example, papillary RCC. Therefore, some studies [4][5][6] have examined whether the contrast enhancement of a renal tumor at CT or MRI can be used to differentiate clear cell RCC from less aggressive subtypes and from benign tumors. Some investigators [7,8]
Materials and Methods
Patients and Inclusion CriteriaThis HIPAA-compliant study received institutional review board approval, and the requirement for informed consent was waived. We retrospectively searched the urology, radiology, and pathology databases at one institution for the time interval March 2006 to Ap...